Core Points - PharmaCorp Rx Inc. has successfully closed a bought deal public offering, raising approximately C$23.0 million through the sale of 54,855,000 units at C$0.42 per unit, including the full exercise of the over-allotment option [1][2] - Each unit consists of one common share and one-half of a common share purchase warrant, with the warrants allowing the purchase of additional shares at C$0.50 until November 12, 2027 [2] - The net proceeds from the offering will be allocated for future acquisition opportunities and general working capital [3] Offering Details - Directors and officers of the company participated in the offering, acquiring a total of 3,762,010 units, which is classified as a related party transaction [4] - The underwriters received a cash commission of 6.0% of the gross proceeds, totaling C$1,134,633, and were issued 2,026,130 broker warrants [5] - The offering was conducted under a prospectus supplement dated November 7, 2025, linked to the company's base shelf prospectus filed with Canadian securities authorities [6] Company Overview - PharmaCorp is a Canadian pharmacy acquisition platform focused on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners [7] - The company operates seven pharmacies under the PharmaChoice Canada banner and aims to expand its network by acquiring both bannered and independent pharmacies [7] - PharmaCorp actively seeks discussions with pharmacy owners considering succession or sale, emphasizing a commitment to seamless transitions [8][9]

Core Insights - PharmaCorp RX Inc. has successfully completed the acquisition of a pre-1954 charter company in Ontario, allowing it to operate pharmacies in the region [1][2] - The acquisition is significant as it enables PharmaCorp to bypass ownership restrictions under the Drug and Pharmacies Regulations Act (Ontario), which limits non-pharmacist owned corporations from operating pharmacies [2] - PharmaCorp currently operates three PharmaChoice bannered pharmacies and plans to continue acquiring more pharmacies under the PharmaChoice Canada brand [3] Company Overview - PharmaCorp operates under the TSX Venture Exchange with the symbol PCRX and is focused on expanding its pharmacy operations in Canada [3] - The company aims to acquire both PharmaChoice Canada branded pharmacies and independently owned non-PharmaChoice Canada bannered pharmacies, integrating them into its operations [3]